Literature DB >> 29789593

[177Lu]PSMA-617 radionuclide therapy shows promise.

Conor A Bradley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29789593     DOI： 10.1038/s41585-018-0029-6

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

Review 1.  Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine.

Authors:  Rubel Chakravarty; Cerise M Siamof; Ashutosh Dash; Weibo Cai
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-08-20

2.  Integrin αvβ3-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy.

Authors:  Haojun Chen; Liang Zhao; Kaili Fu; Qiuming Lin; Xuejun Wen; Orit Jacobson; Long Sun; Hua Wu; Xianzhong Zhang; Zhide Guo; Qin Lin; Xiaoyuan Chen
Journal:  Theranostics       Date:  2019-10-16       Impact factor: 11.556

3.  Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitro.

Authors:  Reshani H Perera; Eric Abenojar; Pinunta Nittayacharn; Xinning Wang; Gopal Ramamurthy; Pubudu Peiris; Ilya Bederman; James P Basilion; Agata A Exner
Journal:  Nanotheranostics       Date:  2022-02-14

4.  PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook.

Authors:  Maximilian A Kirchner; Adrien Holzgreve; Matthias Brendel; Michael Orth; Viktoria C Ruf; Katja Steiger; Dennis Pötter; Lukas Gold; Marcus Unterrainer; Lena M Mittlmeier; Enio Barci; Roland E Kälin; Rainer Glass; Simon Lindner; Lena Kaiser; Jessica Maas; Louisa von Baumgarten; Harun Ilhan; Claus Belka; Johannes Notni; Peter Bartenstein; Kirsten Lauber; Nathalie L Albert
Journal:  Front Oncol       Date:  2021-11-17       Impact factor: 6.244

5.  Quality control and GMP synthesis of 68Ga-prostate-specific membrane antigen-11 for detection of low- and high-grade prostate cancer.

Authors:  Majid Assadi; Habibollah Dadgar
Journal:  World J Nucl Med       Date:  2019-07-23

6.  Radio-enhancement effects by radiolabeled nanoparticles.

Authors:  Yaser Hadi Gholami; Richard Maschmeyer; Zdenka Kuncic
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.